Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 28, Issue 12, 2009, Pages 1477-1482

  Kanafani, Z A ^a   Kourany, W M ^b   Fowler Jr , V G ^c   Levine, D P ^d   Vigliani, G A ^e   Campion, M ^f   Katz, D E ^g   Corey, G R ^c   Boucher, H W ^h  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Vigliani Consulting   (United States)

^f Cubist Pharmaceuticals ^*  (United States)

^g CUBIST PHARMACEUTICALS INC   (United States)

^h TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; GENTAMICIN; PENICILLIN DERIVATIVE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; DIABETES COMPLICATIONS; ENDOCARDITIS, BACTERIAL; FEMALE; GENTAMICINS; HUMANS; MALE; MIDDLE AGED; PENICILLINS; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; VANCOMYCIN;

EID: 71349084863     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-009-0808-3     Document Type: Article

References (32)

1. JD Breen AW Karchmer 1995 Staphylococcus aureus infections in diabetic patients Infect Dis Clin North Am 9 11 24 1:STN:280:DyaK2M3os12msQ%3D%3D 7769212
2. N Joshi GM Caputo MR Weitekamp AW Karchmer 1999 Infections in patients with diabetes mellitus N Engl J Med 341 1906 1912 10.1056/NEJM199912163412507 1:STN:280:DC%2BD3c%2Fks1Gksw%3D%3D 10601511
3. HM Calvet TT Yoshikawa 2001 Infections in diabetes Infect Dis Clin North Am 15 407 421 10.1016/S0891-5520(05)70153-7 1:STN:280:DC%2BD38%2FhvFOmsA%3D%3D 11447703
4. JA Carton JA Maradona FJ Nuno R Fernandez-Alvarez F Perez-Gonzalez V Asensi 1992 Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients Eur J Med 1 281 287 1:STN:280: DyaK2c%2FosVWktA%3D%3D 1341610
5. G Jean B Charra C Chazot, et al. 2002 Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias Nephron 91 399 405 10.1159/000064279 1:STN:280:DC%2BD38zntl2msw%3D%3D 12119469 (Pubitemid 34765237)
6. L Leibovici Z Samra H Konisberger O Kalter-Leibovici SD Pitlik M Drucker 1991 Bacteremia in adult diabetic patients Diabetes Care 14 89 94 10.2337/diacare.14.2.89 1:STN:280:DyaK3M3osVOrtg%3D%3D 2060428
7. PV Sreeramoju J Tolentino S Garcia-Houchins SG Weber 2008 Predictive factors for the development of central line-associated bloodstream infection due to gram-negative bacteria in intensive care unit patients after surgery Infect Control Hosp Epidemiol 29 51 56 10.1086/524334 18171187 (Pubitemid 351267774)
8. K Kreisel K Boyd P Langenberg MC Roghmann 2006 Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia Diagn Microbiol Infect Dis 55 179 184 10.1016/j.diagmicrobio.2006.01. 021 16631340 (Pubitemid 43928410)
9. J Bishara N Peled Z Samra A Sagie L Leibovici S Pitlik 2004 Infective endocarditis in diabetic and non-diabetic patients Scand J Infect Dis 36 795 798 10.1080/00365540410025384 15764163 (Pubitemid 40074013)
10. CH Cabell JG Jollis GE Peterson, et al. 2002 Changing patient characteristics and the effect on mortality in endocarditis Arch Intern Med 162 90 94 10.1001/archinte.162.1.90 11784225
11. R Moreno J Zamorano C Almeria, et al. 2002 Influence of diabetes mellitus on short- and long-term outcome in patients with active infective endocarditis J Heart Valve Dis 11 651 659 12358401
12. IA Critchley DC Draghi DF Sahm C Thornsberry ME Jones JA Karlowsky 2003 Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001 J Antimicrob Chemother 51 639 649 10.1093/jac/dkg130 1:CAS:528:DC%2BD3sXit12ltL4%3D 12615866 (Pubitemid 36336158)
13. RD Arbeit D Maki FP Tally E Campanaro BI Eisenstein 2004 The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections Clin Infect Dis 38 1673 1681 10.1086/420818 1:CAS:528: DC%2BD2cXlvFSjsrg%3D 15227611 (Pubitemid 38781657)
14. VG Fowler Jr HW Boucher GR Corey, et al. 2006 Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus N Engl J Med 355 653 665 10.1056/NEJMoa053783 1:CAS:528:DC%2BD28Xot12mt7k%3D 16914701 (Pubitemid 44244536)
15. R Khatib S Saeed M Sharma K Riederer MG Fakih LB Johnson 2006 Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia Eur J Clin Microbiol Infect Dis 25 181 185 10.1007/s10096-006-0096-0 1:CAS:528:DC%2BD28XisFektb4%3D 16505987
16. JS Li DJ Sexton N Mick, et al. 2000 Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis Clin Infect Dis 30 633 638 10.1086/313753 1:STN:280:DC%2BD3czotl2isA%3D%3D 10770721 (Pubitemid 30736964)
17. WM Kourany JM Miro A Moreno, et al. 2006 Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database Scand J Infect Dis 38 613 619 10.1080/00365540600617017 16857604 (Pubitemid 44144717)
18. VH Chu CH Cabell DK Benjamin Jr, et al. 2004 Early predictors of in-hospital death in infective endocarditis Circulation 109 1745 1749 10.1161/01.CIR.0000124719.61827.7F 15037538 (Pubitemid 38500677)
19. MB Edmond SE Wallace DK McClish MA Pfaller RN Jones RP Wenzel 1999 Nosocomial bloodstream infections in United States hospitals: a three-year analysis Clin Infect Dis 29 239 244 10.1086/520192 1:STN:280: DyaK1MvgsVeluw%3D%3D 10476719
20. JP Steinberg CC Clark BO Hackman 1996 Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance Clin Infect Dis 23 255 259 1:STN:280:DyaK28vjvF2nug%3D%3D 8842259
21. VG Fowler Jr JM Miro B Hoen, et al. 2005 Staphylococcus aureus endocarditis: a consequence of medical progress JAMA 293 3012 3021 10.1001/jama.293.24.3012 1:CAS:528:DC%2BD2MXlsVenurs%3D 15972563 (Pubitemid 40965071)
22. JM Miro I Anguera CH Cabell, et al. 2005 Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database Clin Infect Dis 41 507 514 10.1086/431979 16028160 (Pubitemid 41099645)
23. A Ahluwalia A Sood A Sood R Lakshmy A Kapil RM Pandey 2000 Nasal colonization with Staphylococcus aureus in patients with diabetes mellitus Diabet Med 17 487 488 10.1046/j.1464-5491.2000.00297.x 1:STN:280: DC%2BD3M%2FmsF2ntA%3D%3D 10975221 (Pubitemid 30471347)
24. DS Berman S Schaefler MS Simberkoff JJ Rahal 1987 Staphylococcus aureus colonization in intravenous drug abusers, dialysis patients, and diabetics J Infect Dis 155 829 831 1:STN:280:DyaL2s7jvFCmtg%3D%3D 3819483
25. DG Canario MH Idris BA Cunha 2004 Methicillin-resistant and -sensitive Staphylococcus aureus nasal colonization of insulin-dependent children with juvenile onset diabetes mellitus Am J Infect Control 32 371 372 10.1016/j.ajic.2004.01.007 15454900 (Pubitemid 39348972)
26. G Sakoulas PA Moise-Broder J Schentag A Forrest RC Moellering Jr GM Eliopoulos 2004 Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia J Clin Microbiol 42 2398 2402 10.1128/JCM.42.6.2398-2402.2004 1:CAS:528:DC%2BD2cXlslamtLY%3D 15184410 (Pubitemid 38747480)
27. AP Nunes RP Schuenck CC Bastos, et al. 2007 Heterogeneous resistance to vancomycin and teicoplanin among Staphylococcus spp. isolated from bacteremia Braz J Infect Dis 11 345 350 1:CAS:528:DC%2BD2sXht1aqtbjE 17684637
28. N Plipat G Livni H Bertram RB Thomson Jr 2005 Unstable vancomycin heteroresistance is common among clinical isolates of methiciliin-resistant Staphylococcus aureus J Clin Microbiol 43 2494 2496 10.1128/JCM.43.5.2494-2496. 2005 1:CAS:528:DC%2BD2MXkvFOqtbw%3D 15872293 (Pubitemid 40656277)
29. JL Wang SP Tseng PR Hsueh K Hiramatsu 2004 Vancomycin heteroresistance in methicillin-resistant Staphylococcus aureus, Taiwan Emerg Infect Dis 10 1702 1704 15503416 (Pubitemid 39201539)
30. R Moss B Munt 2003 Injection drug use and right sided endocarditis Heart 89 577 581 10.1136/heart.89.5.577 12695478
31. SW Lagakos 2006 The challenge of subgroup analyses-reporting without distorting N Engl J Med 354 1667 1669 10.1056/NEJMp068070 1:CAS:528: DC%2BD28Xjs12gsL8%3D 16625007
32. HW Boucher 2008 Is it possible to "blind" a trial of community-acquired pneumonia? Clin Infect Dis 47 Suppl 3 S210 S215 10.1086/591428 18986292